The Center for Duchenne Muscular Dystrophy is NOW Soliciting Abstracts for the 2021 CDMD Appel Seed Grant Award
The Appel Seed Grant was established in honor of Josh Bohbot to encourage research relevant to Duchenne Muscular Dystrophy at UCLA CDMD.
Faculty or senior scientists interested in applying should send a bio sketch and a 1-page proposal including; abstract, aims, and significance to DMD.
DEADLINE TO SUBMIT IS 5PM November 16th.
Please send materials to Amy Martin firstname.lastname@example.org
NO LATER than 5pm on November 16, 2020.
The Pilot & Feasibility (P&F) Program funds studies in the area of muscle or muscular dystrophy research. These seed grants are funded through a partnership between an NIH funded P30 grant, the CDMD and the UCLA CTSI. The P&F awards may be focused on basic, translational or clinical research. The goal of the P&F Program is to encourage research on muscle by young researchers who recently became independent or senior investigators either entering the muscle field for the first time or exploring a completely new direction. This year, two to four new grants will be awarded, each for up to $30,000. Studies that broadly advance any aspect of the mission of the CDMD and those which use at least one P30-funded Core facility (indicated in the budget) will be given priority.
Scientists and clinicians working on skeletal and cardiac muscle function in health and disease are encouraged to become members of the Center. Apply for Membership.
The Application and Judging Process
Pilot and feasibility proposals are solicited annually. The CDMD executive committee will consider the merits of each proposal based on the strength of the hypothesis, the experimental approach, the relevance to muscular dystrophy and the potential that the project will lead to an NIH grant application. Funding will be available in May 2018.
The Cores of the Center Learn about the cores
A complete application in NIH format must include the following:
Conditions of Award